You just read:

OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO™

News provided by

OncoSec Medical Incorporated

Apr 06, 2020, 09:00 ET